newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q

  • INVO Fertility received a Nasdaq delinquency notice on May 27, 2026, for failing to timely file its 2025 Form 10-K & 2026 Q1 Form 10-Q.
  • The filing delays were caused by the time required to review complex accounting matters including tax provisions, variable interest entities, & derivative accounting.
  • The company filed the outstanding 2025 10-K on June 2, 2026, & is working to file the 2026 Q1 10-Q as soon as possible.
  • Nasdaq Listing Rule 5250(c)(1) requires timely filing of periodic reports with the SEC, which triggered the notice.
  • The notice has no immediate effect on the listing of INVO common stock, which continues to trade under the symbol "IVF".
  • The company has 60 days from its April 23, 2026, notice to submit a compliance plan by June 22, 2026, with a potential 180-day extension to regain compliance by October 13, 2026.
  • Pending Q1 10-Q results are expected to reflect progress from a $7.5 million financing completed in January 2026 & the acquisition of Family Beginnings.
  • INVO operates four US fertility clinics & sells its proprietary INVOcell medical device to third-party clinics.